$EAPH Recent News Easton Pharmaceuticals Is in R
Post# of 88926
Posted On: 02/11/2014 10:45:41 AM
$EAPH Recent News
Easton Pharmaceuticals Is in Receipt of Proposal to Increase Current Financing; Provides Other Initiative Updates 9:15 a.m. Feb. 10, 2014 - Marketwire
CannabisFN Weekly: Stocks Gear Up Under Canada's New MMPR Regulations 9:01 a.m. Feb. 10, 2014 - ACCESSWIRE
Easton Pharmaceutical, Inc. Analyst Report and Medical Marijuana Initiatives - by BrokerBank Securities, Inc. 7:00 a.m. Feb. 10, 2014 - PR Newswire - PRF
Easton Pharmaceuticals Signs Letter of Intent / NDA, Enters Into Negotiations With Private B.C. Company Who Has Received Federal License Approval on Medical Marijuana & Closes on Agreement to Engage Leading Legal Consultant 9:17 a.m. Feb. 7, 2014 - Marketwire
Easton Pharmaceuticals Announces Update to VIORRA Initiative: Manufacturing Set to Begin 9:32 a.m. Feb. 3, 2014 - Marketwire
TrendingWallStreet.com Releases Begins Analysis on EAPH, PHOT, CMG, and MAT 12:38 a.m. Feb. 3, 2014 - ACCESSWIRE
Easton Pharmaceuticals Moves Towards Formerly Engaging Leading Legal Expert on Medical Marijuana Licence, as Well as Moving to Next Level of Medical Marijuana Negotiations With Request for Term-Sheet and Final Due Diligence Documents 8:02 a.m. Jan. 29, 2014 - Marketwire
Easton Pharmaceuticals Announces Update on Negotiations Towards Its Medical Marijuana Initiatives 8:52 a.m. Jan. 16, 2014 - Marketwire
Easton Pharmaceuticals Provides Update on Initiatives Towards Its Cancer Drug "Xilive" and Its Mexican Government Regulatory Filing Submission for "Viorra" 11:56 a.m. Dec. 11, 2013 - Marketwire
Easton Pharmaceuticals Enters Into Cancer Drug Industry by Acquiring Initial Minority Ownership Interest in Experimental Cancer Drug "XILIVE" With 12 Month Option to Purchase Remaining Interest; Preliminary Feedback Extremely Promising 1:39 p.m. Nov. 6, 2013 - Marketwire
Easton Pharmaceuticals Is Provided a Manufacturing, Regulatory Filing Update and Forward Sales Estimates for VIORRA 8:31 a.m. Nov. 4, 2013 - Marketwire
Easton Pharmaceuticals Announces Formal Agreement & Advances Payment to BMV Medica S.A. Towards a Regulatory Filing in Mexico for "Viorra"; Company Anticipates Approval and Initial Sales by End of Second Quarter 2014 7:03 a.m. Oct. 22, 2013 - Marketwire
Easton Pharmaceuticals Announces Application to Obtain a Distributorship License Towards Its Canadian Medical Marijuana Initiatives 7:01 a.m. Oct. 4, 2013 - Marketwire
Easton Pharmaceuticals Signs LOI to Acquire a Cosmetic Anti-Aging and Beauty Care Line of Products Including a Product to Compliment its Medical Marijuana Initiatives 8:00 a.m. Sept. 27, 2013 - BusinessWire
Easton Pharmaceuticals Re- Enters Drug Market, Acquires 50% Ownership Interest In FSAD Drug And Related Patents / Patent Pendings. Drug Subsequently Underwent Clinical Trials At Cedar-Sinai Medical Center, Beverley Hills, CA. 8:00 a.m. Sept. 16, 2013 - BusinessWire
Easton Pharmaceuticals, Inc. Provides Update on Its Medical Marijuana Initiatives 7:40 a.m. Aug. 23, 2013 - Filing Services Canada
Easton Pharmaceuticals, Inc. Provides Update on Its Medical Marijuana Initiatives 7:40 a.m. Aug. 23, 2013 - BusinessWire
Easton Pharmaceuticals Announces It Has Ordered Ingredients towards Producing Final Test and Trial Samples of Its Re-Formulated Viorra and Other Recently Added Portfolio Products 10:57 a.m. Aug. 14, 2013 - BusinessWire
Easton Pharmaceuticals Announces Three New Additional Products and a Revision to Its Viorra Flagship Product Towards Resuming Its Latin American & South East Asia Initiatives 6:09 p.m. June 7, 2013 - BusinessWire
Easton Pharmaceuticals, Inc. Announces Its Entrance into the Medical Marijuana Sector 3:25 p.m. June 5, 2013 - BusinessWire
Easton Pharmaceuticals Is in Receipt of Proposal to Increase Current Financing; Provides Other Initiative Updates 9:15 a.m. Feb. 10, 2014 - Marketwire
CannabisFN Weekly: Stocks Gear Up Under Canada's New MMPR Regulations 9:01 a.m. Feb. 10, 2014 - ACCESSWIRE
Easton Pharmaceutical, Inc. Analyst Report and Medical Marijuana Initiatives - by BrokerBank Securities, Inc. 7:00 a.m. Feb. 10, 2014 - PR Newswire - PRF
Easton Pharmaceuticals Signs Letter of Intent / NDA, Enters Into Negotiations With Private B.C. Company Who Has Received Federal License Approval on Medical Marijuana & Closes on Agreement to Engage Leading Legal Consultant 9:17 a.m. Feb. 7, 2014 - Marketwire
Easton Pharmaceuticals Announces Update to VIORRA Initiative: Manufacturing Set to Begin 9:32 a.m. Feb. 3, 2014 - Marketwire
TrendingWallStreet.com Releases Begins Analysis on EAPH, PHOT, CMG, and MAT 12:38 a.m. Feb. 3, 2014 - ACCESSWIRE
Easton Pharmaceuticals Moves Towards Formerly Engaging Leading Legal Expert on Medical Marijuana Licence, as Well as Moving to Next Level of Medical Marijuana Negotiations With Request for Term-Sheet and Final Due Diligence Documents 8:02 a.m. Jan. 29, 2014 - Marketwire
Easton Pharmaceuticals Announces Update on Negotiations Towards Its Medical Marijuana Initiatives 8:52 a.m. Jan. 16, 2014 - Marketwire
Easton Pharmaceuticals Provides Update on Initiatives Towards Its Cancer Drug "Xilive" and Its Mexican Government Regulatory Filing Submission for "Viorra" 11:56 a.m. Dec. 11, 2013 - Marketwire
Easton Pharmaceuticals Enters Into Cancer Drug Industry by Acquiring Initial Minority Ownership Interest in Experimental Cancer Drug "XILIVE" With 12 Month Option to Purchase Remaining Interest; Preliminary Feedback Extremely Promising 1:39 p.m. Nov. 6, 2013 - Marketwire
Easton Pharmaceuticals Is Provided a Manufacturing, Regulatory Filing Update and Forward Sales Estimates for VIORRA 8:31 a.m. Nov. 4, 2013 - Marketwire
Easton Pharmaceuticals Announces Formal Agreement & Advances Payment to BMV Medica S.A. Towards a Regulatory Filing in Mexico for "Viorra"; Company Anticipates Approval and Initial Sales by End of Second Quarter 2014 7:03 a.m. Oct. 22, 2013 - Marketwire
Easton Pharmaceuticals Announces Application to Obtain a Distributorship License Towards Its Canadian Medical Marijuana Initiatives 7:01 a.m. Oct. 4, 2013 - Marketwire
Easton Pharmaceuticals Signs LOI to Acquire a Cosmetic Anti-Aging and Beauty Care Line of Products Including a Product to Compliment its Medical Marijuana Initiatives 8:00 a.m. Sept. 27, 2013 - BusinessWire
Easton Pharmaceuticals Re- Enters Drug Market, Acquires 50% Ownership Interest In FSAD Drug And Related Patents / Patent Pendings. Drug Subsequently Underwent Clinical Trials At Cedar-Sinai Medical Center, Beverley Hills, CA. 8:00 a.m. Sept. 16, 2013 - BusinessWire
Easton Pharmaceuticals, Inc. Provides Update on Its Medical Marijuana Initiatives 7:40 a.m. Aug. 23, 2013 - Filing Services Canada
Easton Pharmaceuticals, Inc. Provides Update on Its Medical Marijuana Initiatives 7:40 a.m. Aug. 23, 2013 - BusinessWire
Easton Pharmaceuticals Announces It Has Ordered Ingredients towards Producing Final Test and Trial Samples of Its Re-Formulated Viorra and Other Recently Added Portfolio Products 10:57 a.m. Aug. 14, 2013 - BusinessWire
Easton Pharmaceuticals Announces Three New Additional Products and a Revision to Its Viorra Flagship Product Towards Resuming Its Latin American & South East Asia Initiatives 6:09 p.m. June 7, 2013 - BusinessWire
Easton Pharmaceuticals, Inc. Announces Its Entrance into the Medical Marijuana Sector 3:25 p.m. June 5, 2013 - BusinessWire
(0)
(0)Scroll down for more posts ▼